Financials ConvaTec Group Plc

Equities

CTEC

GB00BD3VFW73

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:18 2024-05-28 am EDT 5-day change 1st Jan Change
251.6 GBX +0.24% Intraday chart for ConvaTec Group Plc -1.10% +3.03%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,213 5,446 5,258 5,748 6,337 6,580 - -
Enterprise Value (EV) 1 6,402 6,437 6,139 6,816 7,467 7,673 7,483 7,259
P/E ratio - 48.6 x 45.1 x 90.8 x 49.3 x 34 x 26.5 x 21.5 x
Yield 2.17% 2.09% 2.25% 2.15% 2% 2% 2.17% 2.31%
Capitalization / Revenue 2.85 x 2.88 x 2.58 x 2.77 x 2.96 x 2.9 x 2.74 x 2.58 x
EV / Revenue 3.5 x 3.4 x 3.01 x 3.29 x 3.49 x 3.39 x 3.12 x 2.85 x
EV / EBITDA 14.4 x 14.5 x 13.2 x 13.6 x 14.2 x 13.5 x 11.9 x 10.4 x
EV / FCF 18.8 x 20.5 x 29 x 49.6 x 29.2 x 27.1 x 22.7 x 18.8 x
FCF Yield 5.32% 4.87% 3.45% 2.02% 3.42% 3.69% 4.41% 5.32%
Price to Book 3.34 x 3.26 x 3.1 x 3.54 x 3.76 x 3.74 x 3.47 x 3.18 x
Nbr of stocks (in thousands) 1,980,983 1,999,499 2,012,171 2,043,129 2,038,814 2,046,697 - -
Reference price 2 2.631 2.724 2.613 2.813 3.108 3.215 3.215 3.215
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,827 1,894 2,038 2,072 2,142 2,266 2,401 2,551
EBITDA 1 443.1 445 464.2 500 527.1 566.7 630.5 697.5
EBIT 1 354.3 350.2 361.7 403.7 431.8 486 544.2 608.3
Operating Margin 19.39% 18.49% 17.75% 19.48% 20.15% 21.45% 22.66% 23.85%
Earnings before Tax (EBT) 1 18.9 174.7 151.3 81.9 167.4 264 329.4 401.6
Net income 1 9.8 112.5 117.6 62.9 130.3 191.7 244.7 302.1
Net margin 0.54% 5.94% 5.77% 3.03% 6.08% 8.46% 10.19% 11.84%
EPS 2 - 0.0560 0.0580 0.0310 0.0630 0.0944 0.1214 0.1492
Free Cash Flow 1 340.4 313.3 211.8 137.5 255.3 283 330.2 386.1
FCF margin 18.63% 16.54% 10.39% 6.63% 11.92% 12.49% 13.75% 15.14%
FCF Conversion (EBITDA) 76.82% 70.4% 45.63% 27.5% 48.43% 49.94% 52.37% 55.35%
FCF Conversion (Net income) 3,473.47% 278.49% 180.1% 218.6% 195.93% 147.63% 134.94% 127.8%
Dividend per Share 2 0.0570 0.0570 0.0587 0.0605 0.0623 0.0643 0.0698 0.0744
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1
Net sales 1 938.3 908 986.3 1,008 511 519.3 1,030 522.2 522.2 1,044 1,028 1,056 1,087 1,110
EBITDA - - 221.6 - - - 211.3 - - - 248.3 - - -
EBIT 189.1 181.8 168.4 204 - - 157.7 - - 204.3 199.4 214.1 217.7 -
Operating Margin 20.15% 20.02% 17.07% 20.24% - - 15.31% - - 19.56% 19.4% 20.28% 20.03% -
Earnings before Tax (EBT) -42.4 - - - - - - - - - 35.8 - - -
Net income -34.7 59.1 53.4 85.8 - - 31.8 - - 48.3 14.6 55.7 - -
Net margin -3.7% 6.51% 5.41% 8.51% - - 3.09% - - 4.62% 1.42% 5.28% - -
EPS -0.0200 0.0300 0.0260 0.0420 - - 0.0160 - - 0.0240 0.007000 0.0270 - -
Dividend per Share 0.0398 - - - - - 0.0415 - - - 0.0433 - - -
Announcement Date 2/28/20 8/6/20 3/5/21 7/30/21 12/8/21 3/8/22 3/8/22 5/4/22 8/4/22 8/4/22 3/9/23 8/2/23 3/6/24 -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,189 991 881 1,068 1,129 1,093 903 679
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.683 x 2.227 x 1.898 x 2.136 x 2.142 x 1.929 x 1.432 x 0.9734 x
Free Cash Flow 1 340 313 212 138 255 283 330 386
ROE (net income / shareholders' equity) 14.6% 14.9% 15.6% 15.5% 16.6% 16.9% 19% 20.4%
ROA (Net income/ Total Assets) 6.38% 6.52% 7.07% 7.07% 7.5% 6.14% 7.27% 8.31%
Assets 1 153.6 1,725 1,664 889.9 1,736 3,123 3,365 3,635
Book Value Per Share 2 0.7900 0.8300 0.8400 0.8000 0.8300 0.8600 0.9300 1.010
Cash Flow per Share 2 0.2000 0.2000 0.1500 0.1400 0.1900 0.2200 0.2500 0.2600
Capex 1 61.4 86.2 94.1 144 129 131 129 133
Capex / Sales 3.36% 4.55% 4.62% 6.96% 6.03% 5.79% 5.37% 5.23%
Announcement Date 2/28/20 3/5/21 3/8/22 3/9/23 3/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.215 USD
Average target price
3.926 USD
Spread / Average Target
+22.10%
Consensus
  1. Stock Market
  2. Equities
  3. CTEC Stock
  4. Financials ConvaTec Group Plc